Written answer
Health Services
1004. Deputy Colm Burke asked the Minister for Health if she is aware of concerns regarding clinical outcomes and the low proportion of patients with established cardiovascular disease in Ireland achieving LDL-C targets recommended by the European Society of Cardiology guidelines; whether the HSE has assessed the impact of current lipid-lowering treatment pathways and restricted reimbursement criteria for PCSK9 inhibitors on the clinical ability to treat high-risk patients to target; and if these reimbursement criteria will be reviewed to align with current European clinical guidelines and the EU Safe Hearts initiative. [79641/26]